To Evaluate the Performance of Total 30 (Lehifilcon A) Contact Lenses in Patients Using Digital Devices for Greater Than 8 Hours Per Day 5 Days Per Week Based on Subjective Reported Data.

Performance of TOTAL30 (Lehfilcon A) Contact Lenses in Patients Using Digital Devices and 89814415

To evaluate the performance of Total 30® (lehfilcon A) contact lenses in patients using digital devices for greater than 8 hours per day 5 days per week based on subjective reported data.

Inclusion Criteria:

• Adult patients aged 18-40 of any sex and any race.
• Reports habitually using digital device usage (phone, Ipad, computer, social media, video streaming) for 8 hours or more per day 5 days per week with plans to continue the habit throughout the study.
• Wearing contact lenses for at least 13 hours daily 5 days per week.
• Spherical refractive error between -11.00 D and +6.00D with < -0.75 D of astigmatism.
• Willing to comply with the protocol instructions.
• Has read (or has had read to), understood, and signed an Informed Consent.
• Willing to not use any artificial tears, rewetting drops or dry eye treatments during the study.

Exclusion Criteria:

• Active ocular infection or ocular inflammatory disease.
• Presbyopic or pre-presbyopic that have a measured add power for reading.
• Current Total 30 contact lens wearer.
• Anterior basement membrane dystrophy or history of recurrent erosion syndrome or topographical abnormalities that might indicate ectasia or other corneal degenerative conditions.
• Current or previous diagnosis of dry eye disease; currently using a dry eye treatment including but not limited to artificial tears, rewetting drops or prescription treatments.
• History of severe / serious ocular pathology or other medical conditions that could result in an inability to safely complete the study.
• Participation by the patient in any other investigational study within the past 30 days.
• Unlikely to comply with protocol instructions for any reason (confusion, substance abuse, etc.). The Principal Investigator or the Medical Monitor reserves the right to declare a patient ineligible based on medical evidence that indicates the patient is unsuitable for the study.
• Inability to utilize Clear Care Cleaning solution.
• Pregnancy